How to Switch From Found to PlexusDx Without Missing a Dose — 2026

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Switching from Found to PlexusDx without missing a dose requires three steps: complete PlexusDx intake before your next Found shipment is due, have a licensed provider review your current therapy and write a new prescription, and coordinate timing so your first PlexusDx medication arrives before your Found supply runs out. The entire process typically takes 3–5 business days from intake to delivery. Most Found members switching to PlexusDx for cash-pay semaglutide or tirzepatide will see their ongoing monthly cost drop by $100–$170 for comparable month-to-month plans, and PlexusDx bills on a calendar-month cycle (12 cycles per year) instead of Found's every-4-weeks schedule (13 cycles per year), which changes the annual cost math significantly.

At-a-glance: Found vs PlexusDx for common switching scenarios

Found pricing verified July 20 and September 4, 2026; PlexusDx pricing verified July 20, 2026. Annual costs are our calculation. Found bills every 4 weeks (13 cycles); PlexusDx bills calendar monthly (12 cycles).

Timing the switch: how to avoid a gap in therapy

The mechanics of switching turn on two timing anchors: when your current Found medication will run out, and how long PlexusDx needs to evaluate your case and ship your first order.

A typical timeline looks like this:

• Day 0: You complete the PlexusDx intake (about 60 seconds) and submit any prior treatment records or recent labs if you have them. No charge at this stage.
• Day 1–2: A licensed clinician reviews your intake, evaluates whether GLP-1 therapy is appropriate, and decides on medication type, route, and starting or continuation dose. The provider may request additional information or a brief telehealth visit if your case requires it.
• Day 2–3: If approved, the prescription is sent to a 503A compounding pharmacy, which prepares and ships your medication.
• Day 3–5: Your first PlexusDx shipment arrives. Shipping is included in the plan price.

To avoid running out, start your PlexusDx intake at least one week before your next Found dose is due. If you are on a weekly injection schedule and you inject every Sunday, complete the PlexusDx intake by the Sunday before your last Found vial will be empty. That buffer accommodates provider review time, any clarifying questions, pharmacy compounding, and transit.

Found allows you to cancel anytime in the app. Once your PlexusDx shipment tracking confirms delivery, cancel your Found subscription so you are not billed for the next 4-week cycle. Found's cancellation policy includes a full refund if you are found not clinically eligible, but that protection applies to initial sign-up; mid-program cancellations follow standard terms, so confirm timing with Found support if you are within a billing window.

Like-for-like cost comparison: what switching saves over 12 months

Found and PlexusDx use different billing cycles, which makes month-to-month prices look closer than the annual totals actually are. Found bills every 4 weeks—13 cycles per year—while PlexusDx bills on a calendar-month schedule, which produces exactly 12 cycles. That one extra cycle per year adds $289–$359 to Found's annual cost for month-to-month plans, depending on compound.

The table below normalizes all plans to 12-month totals. Found's figures are our calculation (advertised monthly rate × 13 cycles); PlexusDx figures are our calculation (advertised monthly rate × 12 cycles). Multi-month prepaid rates are labeled as such.

Found pricing verified July 20 and September 4, 2026; PlexusDx pricing verified July 20, 2026. All 12-month totals are our calculation. Found's 12-month prepaid plans ($2,028 for semaglutide, $2,868 for tirzepatide) require full upfront payment and work out to $169/mo and $239/mo effective rates, respectively. PlexusDx does not offer annual prepay; all plans bill on the stated monthly schedule.

For members currently on Found's month-to-month cash plan, switching to PlexusDx month-to-month delivers annual savings of $1,489 on semaglutide and $1,199 on tirzepatide. If you are willing to commit to a 6-month plan, PlexusDx semaglutide ($149/mo, $1,788/year) still undercuts Found's 6-month rate ($219/mo, $2,847/year) by $1,059 annually.

Found's 12-month prepaid cash plans offer the lowest per-month equivalent in Found's lineup, but they require locking in $2,028 (semaglutide) or $2,868 (tirzepatide) upfront. PlexusDx does not offer annual prepay; the 6-month plan is the longest commitment available. A member who prepaid Found's annual semaglutide plan ($2,028) would pay less over 12 months than PlexusDx month-to-month ($2,268), but more than PlexusDx 3-month ($2,028, identical) or 6-month ($1,788). The decision turns on whether you want the flexibility to adjust therapy mid-year or prefer to minimize total cost by prepaying a full year.

What to expect during the PlexusDx intake and approval process

PlexusDx intake is a short online form asking about your current weight, health history, medications, and weight-management goals. If you are already on GLP-1 therapy through Found, you will indicate your current compound, dose, frequency, and how long you have been on treatment. Providing that context helps the reviewing clinician decide whether to continue your current dose, adjust it, or recommend a different protocol.

You are not required to submit records from Found, but having your most recent dose and any lab work on hand can speed up the review. If you experienced side effects or dose adjustments at Found, mention them in the intake notes so the PlexusDx provider has the full picture.

Once you submit the intake, a licensed clinician (physician, nurse practitioner, or physician assistant, depending on your state) reviews your case. The provider decides:

• Whether you are clinically appropriate for GLP-1 therapy
• Which compound (semaglutide or tirzepatide) and route (injection, oral, microdose) fits your case
• What dose to prescribe, based on your current therapy and response

If the provider approves your prescription, you are charged for your first month (or first billing cycle of a multi-month plan), and the prescription is sent to a licensed 503A compounding pharmacy. The pharmacy prepares your medication and ships it directly to your address. Shipping is included in the plan price. Most members receive their first shipment within 3–5 business days of approval.

If the provider determines that GLP-1 therapy is not appropriate for you—for example, due to a contraindicated condition or medication interaction—you are not charged. PlexusDx does not guarantee approval, dose, or medication type; the licensed clinician makes that decision on a case-by-case basis.

Found advantages that do not transfer to PlexusDx

Found's platform includes features that PlexusDx does not replicate:

• Insurance billing track: Found offers a separate pricing structure for members whose insurance covers GLP-1 therapy. The insurance plan starts at $199/mo (monthly) or $99/mo effective (12-month prepaid) plus medication copays, which typically run around $30. PlexusDx operates cash-pay only and does not bill insurance or process copays. If your insurance covers branded or compounded GLP-1s and you want to use that benefit, Found's insurance track or a traditional in-person provider may deliver lower out-of-pocket cost than PlexusDx cash pricing.
• 24/7 care team and app-based support: Found's monthly plan price includes access to board-certified clinicians, health coaches, and the Aimee AI concierge through the Found app. Members can message their care team, track habits, and receive personalized guidance within the app. PlexusDx includes a free Doctor of Pharmacy check-in but does not offer ongoing app-based messaging or dedicated health coaching. If you value continuous access to a care team for questions about side effects, dose adjustments, or behavioral support, Found's included coaching may justify the higher medication cost.
• Branded GLP-1 option: Found can prescribe and fulfill branded semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) when appropriate, billed separately from the membership plan. PlexusDx offers compounded formulations only (injection, oral, microdose). If you prefer or require a branded product—for example, because your insurance covers it or because you want an FDA-approved drug—Found provides that pathway and PlexusDx does not.

Found holds a 4.1-star rating on Trustpilot with approximately 732 reviews (verified September 4, 2026). PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (verified September 9, 2026). Both providers maintain similar overall satisfaction scores; the decision between them turns on cost structure, feature set, and whether you need insurance billing.

PlexusDx advantages for Found members considering a switch

PlexusDx offers features and pricing structures that may appeal to Found members looking for lower cost or different medication options:

• Lower cash-pay pricing across all plan lengths: PlexusDx month-to-month semaglutide ($189) is $100/month cheaper than Found's month-to-month rate ($289), and the calendar-month billing cycle (12 cycles/year vs Found's 13) amplifies the annual savings. Even Found's 6-month commitment ($219/mo for semaglutide) costs $70/month more than PlexusDx month-to-month, and PlexusDx offers further discounts at 3-month ($169) and 6-month ($149) commitment levels without requiring a full-year prepayment.
• Oral and microdose GLP-1 options: PlexusDx provides compounded semaglutide and tirzepatide in oral capsule form (semaglutide oral $289/mo month-to-month, tirzepatide oral $349/mo month-to-month) and a microdose GLP-1 protocol ($129/mo) designed for maintenance or members who do not tolerate standard doses. Found's compounded offerings are injectable only; oral and microdose routes are not available. If you want to avoid injections or step down to a lower maintenance dose, PlexusDx provides those formats and Found does not.
• No separate membership fee: Found's monthly plan price covers medication, app access, and care team support as a bundled membership. PlexusDx pricing is medication-only; your monthly payment includes the provider visit, prescription, compounded drug, and shipping, with no additional membership layer. If you do not use app-based coaching or 24/7 messaging, PlexusDx's structure lets you pay only for the clinical service and medication.
• Flat pricing at every dose: PlexusDx charges the same monthly rate regardless of dose level. Whether you are on 0.25 mg semaglutide or 2.4 mg, the price is $189/mo (month-to-month injection). Found's pricing does not vary by dose either, but PlexusDx makes that policy explicit, which simplifies budgeting as you titrate.
• Optional genetic testing: PlexusDx offers a genetic test ($298 standalone, $99 for program members) that analyzes genetic variants associated with drug metabolism and response. The test does not select your medication—your provider makes that decision based on clinical criteria—but it can inform discussions about side-effect risk or dose adjustment. Found does not offer genetic testing as part of its platform.

Choose Found if…

Found remains the better fit for members who:

• Have insurance coverage for GLP-1 therapy and want to use it. Found's insurance track can reduce out-of-pocket cost below PlexusDx cash pricing when your plan covers the medication and your copay is reasonable.
• Value integrated app-based support and coaching. If 24/7 access to a care team, habit tracking, and AI-assisted guidance are central to your weight-management strategy, Found's bundled membership model delivers those features and PlexusDx does not.
• Want the option of branded GLP-1 medications. Found can prescribe Wegovy, Ozempic, Zepbound, or Mounjaro when clinically appropriate. PlexusDx offers compounded formulations exclusively.
• Prefer to lock in the lowest possible per-month rate with an annual prepayment. Found's 12-month prepaid plans ($169/mo effective for semaglutide, $239/mo effective for tirzepatide) deliver the lowest monthly cost in Found's lineup and are competitive with PlexusDx's shorter-term commitments, if you are comfortable with the upfront spend and a full-year commitment.

Choose PlexusDx if…

PlexusDx is the stronger choice for members who:

• Are paying cash for GLP-1 therapy and want the lowest ongoing monthly cost without a multi-thousand-dollar upfront commitment. PlexusDx month-to-month semaglutide ($189) and tirzepatide ($289) undercut Found's month-to-month rates by $100–$70, and the 6-month plans deliver even larger annual savings.
• Prefer calendar-month billing. PlexusDx bills on the 1st of each month (or your enrollment date anniversary), which aligns with typical personal budgeting cycles and results in exactly 12 charges per year. Found's every-4-weeks schedule produces 13 cycles annually, adding one extra billing event that many members find harder to predict.
• Want oral GLP-1 or microdose options. If you want to avoid injections or transition to a lower maintenance dose, PlexusDx offers oral semaglutide, oral tirzepatide, and microdose GLP-1 protocols that Found does not provide.
• Do not need or use ongoing app-based coaching. If you are comfortable managing therapy with periodic provider check-ins and do not rely on daily habit tracking or messaging support, PlexusDx's medication-focused model eliminates the cost of features you do not use.
• Are interested in genetic insights. PlexusDx members can add a genetic test for $99 (vs $298 standalone) to explore how genetic variants may influence GLP-1 metabolism and side-effect risk. The test does not determine your prescription, but it can inform shared decision-making with your provider.

Where PlexusDx fits in your switching decision

PlexusDx is built for members who prioritize transparent cash pricing, medication format flexibility, and no-bundling—pay for the drug and clinical oversight, nothing else. The month-to-month semaglutide plan at $189 is $100/month cheaper than Found's equivalent, and that gap widens to $1,489/year when you account for Found's 13-cycle billing schedule. The 6-month semaglutide commitment ($149/mo, $1,788/year) undercuts Found's 6-month rate by $1,059 annually and does so without requiring a full-year prepayment.

If you are switching primarily to lower cost and you do not need insurance billing or app-based coaching, PlexusDx delivers the largest cash savings on ongoing therapy. If you want to explore oral GLP-1 or microdose formats—routes that Found does not offer in compounded form—PlexusDx provides those options at transparent monthly rates with no membership layer.

The intake takes about 60 seconds, a licensed provider reviews your case within 1–2 business days, and most approved prescriptions ship within 3–5 days total. Start your intake at least one week before your next Found dose is due, confirm delivery tracking, then cancel your Found subscription to avoid overlapping charges.

Methodology and freshness

Pricing, plan structures, and medication formats for Found were verified from the provider's public website and checkout flows on July 20, 2026 and September 4, 2026. PlexusDx pricing and product details were verified from plexusdx.com on July 20, 2026. Trustpilot ratings and review volumes for both providers were captured on September 4, 2026. All 12-month cost projections are our calculation, derived by multiplying the advertised monthly rate by the provider's billing cycle count (13 cycles/year for Found's every-4-weeks schedule, 12 cycles/year for PlexusDx's calendar-month schedule). Found's 12-month prepaid figures are the provider's advertised upfront totals, which we converted to effective per-month equivalents for comparison purposes and labeled as prepaid. No promotional codes, discount arithmetic, or unadvertised pricing appears in this analysis. Switching timelines and intake processes reflect standard telehealth GLP-1 workflows; individual cases may require additional provider communication or documentation, which can extend the timeline. We will update this guide when either provider changes its pricing, plan structure, or medication offerings.

Frequently Asked Questions

Can I transfer my current Found prescription directly to PlexusDx?

No. PlexusDx operates through independent licensed providers who must evaluate your case and write a new prescription. You cannot transfer an active prescription from Found to PlexusDx. Instead, you complete a new intake, a PlexusDx-affiliated clinician reviews your history and current therapy, and that provider decides whether to prescribe GLP-1 and at what dose. The process typically takes 1–2 business days from intake to approval.

Will my dose change when I switch from Found to PlexusDx?

Possibly. The PlexusDx provider reviews your current dose, how long you have been on therapy, your response, and any side effects you have experienced. In many cases, the provider continues the same dose you were taking at Found. However, the provider may adjust the dose up or down based on clinical judgment, or recommend a different compound or route. Dose decisions are made on a case-by-case basis and are not guaranteed to match your prior therapy.

How do I avoid running out of medication during the switch?

Start your PlexusDx intake at least one week before your next Found dose is due. This buffer allows time for provider review (1–2 days), pharmacy compounding and shipping (2–3 days), and any clarifying questions the provider may have. Once your PlexusDx shipment tracking confirms delivery, cancel your Found subscription in the Found app so you are not billed for the next cycle. Do not cancel Found until your PlexusDx medication is in hand.

Does PlexusDx offer the same app-based coaching and support that Found includes?

No. Found's monthly plan includes 24/7 access to a care team, health coaches, and an AI concierge through the Found app. PlexusDx provides a free Doctor of Pharmacy check-in and standard clinical support, but does not offer ongoing app-based messaging, habit tracking, or dedicated health coaching. If you rely on daily interactive support, Found's bundled model may be worth the higher medication cost. If you are comfortable with periodic provider contact, PlexusDx's lower pricing reflects the absence of those features.

Can I use insurance with PlexusDx the way I can with Found?

No. PlexusDx operates on a cash-pay basis only and does not bill insurance or process copays. Found offers a separate insurance pricing track (starting at $199/mo monthly or $99/mo effective for a 12-month prepaid plan, plus medication copays) for members whose plans cover GLP-1 therapy. If you have insurance coverage for weight-management medications and want to use that benefit, Found or a traditional in-person provider may deliver lower out-of-pocket cost than PlexusDx cash pricing.

Sources

• PlexusDx vs Found comparison page, plexusdx.com, accessed July 20, 2026
• Found Weight Loss official pricing page, joinFound.com, accessed September 4, 2026
• PlexusDx product pages (semaglutide injection, tirzepatide injection, oral semaglutide, oral tirzepatide, microdose GLP-1), plexusdx.com, accessed July 20, 2026
• Found plan and medication details, competitor_companies.csv research extract, captured September 4, 2026
• Found pricing structures, plan_pricing.csv research extract, captured September 4, 2026
• Trustpilot ratings for Found and PlexusDx, competitor_reviews.csv research extract, captured September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.